Lv1
40 积分 2025-08-08 加入
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
5个月前
已完结
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
5个月前
已完结
Clinical Validation of a Circulating Tumor DNA-Based Blood Test to Screen for Colorectal Cancer
6个月前
已完结
皖公网安备34019202002308
